Thrombotic, Inflammatory & Gene Markers of CVD in Women

Clinical Trial ID NCT00006539

PubWeight™ 71.21‹?›

🔗 Visit the page for NCT00006539

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 16.23
2 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 15.85
3 Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003 8.29
4 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003 6.99
5 Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 2002 2.84
6 C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004 2.08
7 Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med 2004 1.76
8 High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004 1.69
9 Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med 2003 1.62
10 Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003 1.56
11 C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis. J Thromb Haemost 2004 1.46
12 Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 2002 1.46
13 A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction. Thromb Haemost 2001 1.45
14 C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 2003 1.43
15 Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002 1.42
16 Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum Mol Genet 2003 1.33
17 Prevalence and 3-year incidence of abuse among postmenopausal women. Am J Public Health 2004 1.19
18 Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 2004 0.96
19 C-reactive protein and risk of cardiovascular disease: evidence and clinical application. Curr Atheroscler Rep 2003 0.92
20 Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction. Atherosclerosis 2004 0.88
21 Prospective evaluation of the alcohol dehydrogenase gamma1/gamma2 gene polymorphism and risk of stroke. Stroke 2004 0.80
22 A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke. Stroke 2002 0.79
Next 100